Kwadwoteng Ventures Pharmaceutical Import Profile — Ghana (DGFT 2022–2026)

Name: Kwadwoteng Ventures Pharmaceutical Import Records from India — 2 Products, $400.0K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Kwadwoteng Ventures — Pharmaceutical Importer Profile (2026) | 2 Products, $400.0K Trade | TransData Nexus

Kwadwoteng Ventures

Pharmaceutical Importer · Ghana · Analgesics & Antipyretics Focus · $400.0K Total Trade · DGFT Verified

Kwadwoteng Ventures is a pharmaceutical importer based in Ghana with a total trade value of $400.0K across 2 products in 2 therapeutic categories. Based on 8 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Kwadwoteng Ventures sources from 3 verified Indian suppliers, with Prg Pharma Private Limited accounting for 95.5% of imports.

Kwadwoteng Ventures — Import Portfolio & Supplier Network

Kwadwoteng Ventures import network — 2 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Kwadwoteng Ventures?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Prg Pharma Private Limited	$4.6M	553	95.5%
Real Drugs Private Limited	$150.0K	3	3.1%
Mg Lifecare Llp	$67.3K	7	1.4%

What Formulations Does Kwadwoteng Ventures Import?

Formulation	Value	Ships
Pharmaceutical products/harmless medicines cough syrup 100 ML, composition:- Each 5 ML. dispensary cup contains	$979.1K	24
Pharmaceutical products/harmless medicines diphenydramine hcl13.5MG,code. phos.11.95MG,sod.cit. bp54.4MG,men.1.1MG	$652.4K	144
Pharmaceutical products/harmless medicines diphenydramine hcl13.5MG,code. phos.11.95MG,sod.cit. bp54.4MG,men.1.1MG	$593.5K	113
Pharmaceutical products/harmless medicines diphenydramine hcl13.5MG,code. phos.11.95MG,sod.cit. bp54.4MG,men.1.1MG	$583.0K	138
Pharmaceutical products/harmless medicines diphenydramine hcl 13.5MG codeine phosphate 11.95MG sodium citrate BP 54.4MG	$250.0K	5
Pharmaceutical products/harmless medicines cough syrup 100 ML composition:- Each 5 ML. dispensary cup contains	$250.0K	5
Pharmaceutical products/harmless medicines cough syrup 100 ML composition:- Each 5 ML. dispensary cup contains	$190.1K	6
Pharmaceutical products/harmless medicines cough syrup 100 ML, composition:- Each 5 ML. dispensary cup contains	$176.5K	4
Pharmaceutical products/harmless medicines cough syrup 100 ML composition:- Each 5 ML. dispensary cup contains	$129.6K	6
Pharmaceutical products/harmless medicines diphenydramine hcl13.5mgcode. phos.11.95mgsod.cit.	$129.4K	10
Pharmaceutical products/harmless	$113.4K	4
Pharmaceutical products/harmless medicines cough syrup 100 ML composition:- Each 5 ML. dispensary cup contains	$100.0K	2
Pharmaceutical products/harmless medicines Each film coated tablet contains tapentadol hcl 125 mgcarisoprodol USP 100MG	$100.0K	2
Diphenhydramine hydrochloride b.p 13.5mgcodiene phosphate BP 11.95MG sodium citrate bp5 4.4MG menthol BP 1.1MG	$100.0K	2
Diphenhydramine hydrochloride b.p 13.5mgcodiene phosphate BP 11.95MG sodium citrate bp5 4.4MG menthol BP 1.1MG	$50.0K	1

Kwadwoteng Ventures imports 59 distinct pharmaceutical formulations. Showing top 15 by value. For full formulation-level data, contact TransData Nexus.

Import Portfolio — Top 2 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Codeine	Analgesics & Antipyretics	$250.0K	5	0.2%	9
2	Diphenhydramine	Antihistamines & Allergy	$150.0K	3	0.5%	15

Kwadwoteng Ventures imports 2 pharmaceutical products across 2 categories into Ghana totaling $400.0K.

Kwadwoteng Ventures — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Kwadwoteng Ventures is a pharmaceutical importer based in Ghana, specializing in the procurement of finished pharmaceutical formulations from India. The company operates as a corporate entity, duly registered with the Registrar-General's Department and licensed by the Food and Drugs Authority (FDA) of Ghana. While specific details about its parent company are not publicly available, Kwadwoteng Ventures plays a significant role in Ghana's pharmaceutical distribution network, facilitating the availability of essential medications to meet the country's healthcare needs.

2Distribution Network

Kwadwoteng Ventures maintains a distribution network that ensures the efficient delivery of pharmaceutical products across Ghana. While specific warehouse locations and logistics capabilities are not publicly disclosed, the company's operations are likely centered around major urban areas to facilitate timely distribution. The geographic coverage primarily spans Ghana, with no publicly available information indicating operations beyond the country's borders.

3Industry Role

In Ghana's pharmaceutical supply chain, Kwadwoteng Ventures functions as a primary wholesaler, importing finished pharmaceutical formulations from India and distributing them to various stakeholders within the healthcare sector. The company's role is crucial in ensuring the availability of essential medications, thereby supporting the country's healthcare infrastructure.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Kwadwoteng Ventures

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Kwadwoteng Ventures demonstrates a high level of supplier concentration, with 95.5% of its total import value sourced from PRG Pharma Private Limited. This significant dependency on a single supplier may pose risks related to supply chain disruptions, pricing fluctuations, and potential challenges in negotiating favorable terms. The limited number of suppliers and shipments suggest a need for diversification to enhance supply chain resilience and mitigate potential risks associated with over-reliance on a single source.

2Supply Chain Resilience

The resilience of Kwadwoteng Ventures's Indian supply chain appears limited due to the heavy reliance on a single supplier, PRG Pharma Private Limited. The absence of backup suppliers and the narrow range of formulations imported indicate potential vulnerabilities in the supply chain. Diversifying suppliers and expanding the range of imported formulations could enhance resilience, reduce dependency risks, and improve the company's ability to adapt to market changes and disruptions.

3Strategic Implications

Importing Pharmaceuticals into Ghana — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Ghana

1Regulatory Authority & Framework

The Food and Drugs Authority (FDA) is the national regulatory body in Ghana responsible for overseeing the safety, quality, and efficacy of pharmaceutical products. Established in 1997 under the Food and Drugs Law, 1992 (PNDCL 305B), and operating under the Public Health Act, 2012 (Act 851), the FDA regulates the manufacture, importation, exportation, sale, and distribution of food, drugs, cosmetics, medical devices, and household chemical substances. The FDA's mandate includes ensuring that all pharmaceutical products meet established standards before they are permitted for sale in Ghana. (moh.gov.gh)

2Import Licensing & GMP

Importers of pharmaceutical products into Ghana must obtain an import license from the FDA. The application process involves submitting an Import Declaration Form and applying for an FDA import permit, which is valid for one year. Importers are required to register with the FDA and ensure that all imported products are registered with the authority. Additionally, the FDA mandates that imported pharmaceutical products comply with Good Manufacturing Practice (GMP) standards. Recognized GMP certifications include those from the European Union (EU GMP), World Health Organization (WHO GMP), and the Pharmaceutical Inspection Co-operation Scheme (PIC/S). Importers must ensure that their suppliers hold valid GMP certifications to meet FDA requirements. (fdaghana.gov.gh)

Kwadwoteng Ventures — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Kwadwoteng Ventures focuses on importing analgesics and antipyretics, as well as antihistamines and allergy medications. The significant import value of Codeine and Diphenhydramine indicates a strategic emphasis on these therapeutic areas, likely driven by consistent market demand for pain relief and allergy treatments in Ghana. The company's product strategy aligns with the healthcare needs of the population, addressing prevalent conditions that require effective pharmaceutical interventions.

2Sourcing Profile

Kwadwoteng Ventures primarily sources generic pharmaceutical products from India, focusing on finished formulations such as tablets, capsules, syrups, and injections. The company's sourcing strategy emphasizes cost-effectiveness and reliability, leveraging India's established pharmaceutical manufacturing capabilities. This approach enables Kwadwoteng Ventures to provide essential medications to the Ghanaian market at competitive prices, meeting the therapeutic needs of the population.

3Market Positioning

Based on its product mix, Kwadwoteng Ventures serves the wholesale distribution segment of the Ghanaian pharmaceutical market. By importing and distributing essential medications, the company plays a pivotal role in ensuring that retail pharmacies, hospitals, and other healthcare providers have access to necessary pharmaceutical products. This positioning underscores Kwadwoteng Ventures's commitment to supporting the healthcare infrastructure and improving patient outcomes in Ghana.

Seller's Guide — How to Become a Supplier to Kwadwoteng Ventures

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to engage with Kwadwoteng Ventures, particularly by offering alternative sources for the products currently imported from PRG Pharma Private Limited. Diversifying the supplier base could enhance supply chain resilience and provide Kwadwoteng Ventures with more competitive pricing and product options. Additionally, introducing a broader range of formulations could address unmet market needs and strengthen the company's position in the Ghanaian pharmaceutical market.

2Requirements & Qualifications

Indian exporters seeking to supply Kwadwoteng Ventures and the Ghanaian market must ensure that their products are registered with the FDA and comply with GMP standards recognized by the FDA, such as EU GMP, WHO GMP, or PIC/S certifications. Products must meet the FDA's quality and labeling requirements, including batch testing, stability, and labeling in English with all necessary information. Additionally, exporters must adhere to the FDA's import guidelines, including obtaining the necessary import permits and ensuring that products are not on the FDA's list of banned or restricted substances. (fdaghana.gov.gh)

3How to Approach

Frequently Asked Questions — Kwadwoteng Ventures

What products does Kwadwoteng Ventures import from India?

Kwadwoteng Ventures imports 2 pharmaceutical products across 2 categories. Top imports: Codeine ($250.0K), Diphenhydramine ($150.0K).

Who supplies pharmaceuticals to Kwadwoteng Ventures from India?

Kwadwoteng Ventures sources from 3 verified Indian suppliers. The primary supplier is Prg Pharma Private Limited (95.5% of imports, $4.6M).

What is Kwadwoteng Ventures's total pharmaceutical import value?

Kwadwoteng Ventures's total pharmaceutical import value from India is $400.0K, based on 8 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Kwadwoteng Ventures focus on?

Kwadwoteng Ventures imports across 2 categories. The largest: Analgesics & Antipyretics (62.5%), Antihistamines & Allergy (37.5%).

Get Full Kwadwoteng Ventures Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.